TD Cowen reaffirms USD 117.00 target for Establishment Labs stock

Published on 10/20/2026 at 21:17 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Revenue rose 31.70 percent to USD 67.54 million. Establishment Labs stock costs EUR 54.04 on October 20, 2026 and Nasdaq quoted USD 60.95.

Analyst target and reporting date

TD Cowen reaffirmed a USD 117.00 target on October 15, 2026.
Second-quarter revenue rose 31.70 percent to USD 67.54 million.
Establishment Labs stock costs EUR 54.04 at Lang & Schwarz on October 20, 2026 at 9:11 p.m. CEST.
Third-quarter results are scheduled for October 29, 2026.

ESTA, VGG312491084, Illustration mit AI erstellt.

Establishment Labs (VGG312491084) generated USD 67.54 million in second-quarter revenue, up 31.70 percent from the same period a year earlier. According to Investing.com on October 15, 2026, TD Cowen reiterated a Buy rating and a USD 117.00 price target. Establishment Labs was trading at EUR 54.04 at Lang & Schwarz on October 20, 2026 at 9:11 p.m. CEST.

Revenue growth meets a loss

The second-quarter revenue figure came with a consolidated net loss of USD 11.74 million and diluted earnings per share of minus USD 0.39, according to Benzinga in its transcript of the August 6, 2026 earnings call. Adjusted EBITDA reached USD 3.70 million, compared with a loss of USD 8.50 million in the year-earlier quarter, while one-time restructuring and debt refinancing charges totaled USD 2.20 million.

How far is the USD 117.00 target?

Nasdaq quoted Establishment Labs at USD 60.95 at 3:16 p.m. ET on October 20, 2026. The TD Cowen target therefore stood 91.96 percent above that Nasdaq quote, using the same currency. The stock traded between USD 47.00 and USD 97.59 over the 52 weeks ending October 20, 2026, placing the quote 37.55 percent below the high and 29.68 percent above the low.

October 29 sets the next date

Business Wire reported on October 19, 2026 that Establishment Labs plans to publish third-quarter results before the market opens on October 29, 2026, for the quarter ended September 30, 2026. The company also plans an earnings call at 8:30 a.m. ET on that date.

Peer valuation remains mixed

Comparison with peers: Establishment Labs: Nasdaq, USD, 0.00 percent daily change unavailable for the euro quote, market capitalization USD 1.8 billion. Abbott Laboratories: NYSE, USD, down 1.76 percent, P/E 32.83, market capitalization USD 176.9 billion. Align Technology: Nasdaq, USD, up 0.47 percent, P/E 25.98, market capitalization USD 10.6 billion.

Price and dates

The immediate investor contrast is clear: the USD 117.00 analyst target sits well above the latest Nasdaq quote, while the company remains loss-making on a consolidated basis. The October 29 results date will provide the next reported test of the USD 269.00 million to USD 271.00 million full-year revenue guidance discussed for 2026.

The further course of trading is shown by the continuously updated real-time quote of Establishment Labs stock.